Origen de la red de primer grado Elliot Young.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
UBS Warburg, Inc.
14
| Subsidiary | 14 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Elliot Young a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Riverview Realty Partners LLC
Riverview Realty Partners LLC Real Estate Investment TrustsFinance Riverview Realty Partners LP provides real estate investment services. It develops, promotes, and implement environmentally sustainable and energy conserving initiatives through innovative and responsible building operations and collaboration with our tenant partners. The company was founded on July 21, 1997 and is headquartered in Chicago, IL | Real Estate Investment Trusts | Director/Board Member | |
CH Energy Group, Inc.
CH Energy Group, Inc. Gas DistributorsUtilities CH Energy Group, Inc. is a holding company, which engages in the provision of natural gas and electric utility services. It operates through the following segments: Electric, Natural Gas, and Other Businesses and Investments. The Other Businesses and Investments segment consists of holding company's activities. The company was founded in 2000 and is headquartered in Poughkeepsie, NY. | Gas Distributors | Director/Board Member | |
Voya Capital LLC | Corporate Officer/Principal | ||
Cellzome Ltd.
Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
CENKOS SECURITIES | Investment Banks/Brokers | Corporate Officer/Principal | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Chairman | |
Tal Medical, Inc.
Tal Medical, Inc. Medical SpecialtiesHealth Technology Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA. | Medical Specialties | Chief Executive Officer | |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
George Washington University | College/University | Masters Business Admin | |
Imperial College London | College/University | Doctorate Degree | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Five Mile Capital Partners LLC
Five Mile Capital Partners LLC Investment ManagersFinance Founded in 2003, Five Mile Capital Partners LLC is a registered investment advisor and hedge fund manager located in Stamford, Connecticut. The firm focuses mainly on fixed income and credit products for institutional clients and high net-worth individuals. | Investment Managers | Portfolio Manager-Equities | |
Lebanon Valley College | College/University | Undergraduate Degree | |
Baylor College of Medicine | College/University | Corporate Officer/Principal | |
Khosla Ventures LLC
Khosla Ventures LLC Investment ManagersFinance Khosla Ventures LLC (Khosla Ventures) is a venture capital firm founded in 2004 by Vinod Khosla. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
UBS AG (Broker) | Investment Banks/Brokers | Analyst-Equity | |
Profi Mangement AB | Founder | ||
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Profi Fastigheter II AB | Chairman | ||
Cross Country Infrastructure Services, Inc.
Cross Country Infrastructure Services, Inc. Wholesale DistributorsDistribution Services Cross Country Infrastructure Services, Inc. engages in the supply of materials, tools, equipment, and parts for the pipeline construction industry. The company is headquartered in Aurora, CO. | Wholesale Distributors | Director/Board Member | |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Founder | |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
F-Star Beta Ltd.
F-Star Beta Ltd. BiotechnologyHealth Technology F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | Medical/Nursing Services | Founder | |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
F-Star Delta Ltd.
F-Star Delta Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., F-Star Delta Ltd. develops antibody products to improve the treatment of serious diseases. The company is based in Cambridge, UK and was founded in 2016. | Pharmaceuticals: Major | Director/Board Member | |
Queen's University Belfast A.F.C. | College/University | Undergraduate Degree | |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services EveryONE Medicines, Inc. delivers individualized precision therapeutics customized to the unique pathogenic genetic mutation of patients. EveryONE Medicines is based in Boston, MA. The company's goal is to provide quality of life to patients by slowing or even halting their disease. The company was founded by Julia Vitarello and Keith Flanagan. The CEO is Nessan Bermingham. | Miscellaneous Commercial Services | Chief Executive Officer | |
Charm Therapeutics Ltd.
Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member | |
Liberate Bio, Inc.
Liberate Bio, Inc. BiotechnologyHealth Technology Liberate Bio, Inc. develops novel genetic medicines. The company is based in Boston, MA. The company was founded by Michael Mitchell, Nessan Bermingham, Stephen Scully, Theresa M. Reineke. The CEO is Shawn Davis. | Biotechnology | Founder | |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman |
Estadísticas
Internacional
Estados Unidos | 27 |
Reino Unido | 13 |
Canadá | 4 |
Austria | 4 |
Dinamarca | 3 |
Sectorial
Health Technology | 22 |
Finance | 12 |
Consumer Services | 6 |
Commercial Services | 3 |
Health Services | 3 |
Operativa
Director/Board Member | 86 |
Corporate Officer/Principal | 45 |
Chairman | 24 |
Independent Dir/Board Member | 19 |
Chief Executive Officer | 13 |
Las relaciones más conectadas
Insiders | |
---|---|
Nessan Bermingham | 36 |
Jim Feuille | 30 |
Richard Colterjohn | 17 |
Colin Buchan | 16 |
Charles Ricketts | 13 |
Michelle MacKay | 12 |
Douglas T. Tansill | 11 |
Bert Roberts | 11 |
Per Afrell | 10 |
Daniel Koller | 9 |
James Graham Glasgow | 9 |
E. Michel Kruse | 7 |
Robert Aikman | 7 |
Rei Shinozuka | 4 |
- Bolsa de valores
- Insiders
- Elliot Young
- Conexiones Empresas